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Oral Presentation 01.2

R&D INVESTMENT LINK TO PROFITABILITY:
A PHARMACEUTICAL INDUSTRY EVALUATION

Lawrence J. Nord and Haria Ossella-Durbal*
Economics Department, Illinois Wesleyan University

This paper is an in depth analysis of the influence that investment into research and development
has on a firm's profitability in the pharmaceutical industry in the United States. The
pharmaceutical industry is chosen due to its high intensity of research and development
expenditures. The top 18 companies in the pharmaceutical industry are gathered and organized as
panel data dating over the recent regression, which encompassed three years. The data are
analyzed through regression and descriptive statistics.
The argument made is that as more funds are invested into research and development a firm in
the pharmaceutical industry will experience a higher market value. Theoretically as firms spend
more on research and development they are increasing the likelihood of innovation, which will
cause growth in the company. The results of this study agree, and a positive and significant
relationship is found between research and development expenditures and market value.

